SILO PHARMA, INC. Conversion of Stock, Shares Converted
SILO PHARMA, INC. (SILO) reported Conversion of Stock, Shares Converted of 13.50 million shares for the 0-month period ending 2021-04-14, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2022-03-28
- 2021-04-14: Conversion of Stock, Shares Converted 0 month 13.50M shares.
- 2021-01-18: Conversion of Stock, Shares Converted 1 month 8.50M shares.
- 2020-08-03: Conversion of Stock, Shares Converted 0 month 2.00M shares.
| Period end | Conversion of Stock, Shares Converted 0 month | Conversion of Stock, Shares Converted 1 month |
|---|---|---|
| 2021-04-14 | 13.50M shares 10-K · filed 2022-03-28 | |
| 2021-01-18 | 8.50M shares 10-K · filed 2022-03-28 | |
| 2020-08-03 | 2.00M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |